Paragon Financial Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Paragon Financial Partners's MRK Position: Q2 2026 in Review
Paragon Financial Partners increased its Merck (MRK) stake by 12% in Q2 2026, buying an estimated $41.7K and bringing the position to 3,439 shares worth $448K. The position accounts for 0.24% of the portfolio, ranked #55.
Paragon Financial Partners first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $506K in Q1 2024. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Paragon Financial Partners held 3,439 shares of Merck worth $448K as of Q2 2026.
- Paragon Financial Partners bought 356 Merck shares in Q2 2026, an estimated $41.7K.
- Merck made up 0.24% of Paragon Financial Partners's portfolio in Q2 2026, its #55 holding.
- Paragon Financial Partners first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
- Paragon Financial Partners's Merck position peaked at $506K in Q1 2024.
- 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Paragon Financial Partners's 13F filing for Q2 2026, filed 7 Aug 2026.